# Lecture 6: Pregnancy Physiology
## Unit 2.4: Reproductive System
---
## Learning Objectives
By the end of this lecture, students will be able to:
1. Describe fertilization and early embryonic development
2. Explain implantation and placental development
3. Describe the maternal physiologic adaptations to pregnancy
4. Explain placental hormone production and functions
5. Describe fetal physiology and development
6. Explain the endocrinology of pregnancy maintenance
---
## Section 1: Fertilization - Gamete Transport and Union
Fertilization represents the union of male and female gametes to create a new diploid organism, occurring within the ampullary region of the fallopian tube. This process requires precise coordination of sperm transport, oocyte release, and molecular recognition events.
Sperm transport begins with ejaculation of approximately 200-300 million spermatozoa into the vaginal fornix. The cervical mucus serves as a selective filter; around ovulation, estrogen dominance produces abundant, watery, acellular mucus with parallel micelles that facilitate sperm passage, while progesterone-dominated mucus is thick and impenetrable. Uterine contractions, enhanced by prostaglandins in seminal fluid, assist sperm transport toward the tubes. Of the millions deposited, only approximately 200 sperm reach the ampulla, having survived the hostile vaginal environment and navigated the female tract.
Capacitation, the final maturation process occurring over several hours within the female reproductive tract, is essential for fertilization. During this process, cholesterol efflux from the sperm membrane increases fluidity, membrane potential changes occur, and intracellular calcium rises. Capacitated sperm exhibit hyperactivated motility characterized by vigorous, whip-like tail movements necessary for zona penetration.
The oocyte, arrested in metaphase II of meiosis, is released at ovulation surrounded by the corona radiata (layers of cumulus cells) and the zona pellucida (glycoprotein matrix). Fimbrial cilia sweep the cumulus-oocyte complex into the tube, where cilia and smooth muscle peristalsis transport it toward the uterus. The oocyte remains viable for approximately 24 hours post-ovulation.
The fertilization sequence proceeds through defined steps. Sperm first penetrate the corona radiata using hyaluronidase released from the sperm surface. Reaching the zona pellucida, sperm bind ZP3 glycoprotein, triggering the acrosome reaction—exocytosis of the acrosomal contents including acrosin, a serine protease that digests the zona matrix. The sperm penetrates the zona, reaching the perivitelline space. Sperm-oocyte membrane fusion triggers the cortical reaction: calcium waves propagate through the oocyte cytoplasm, releasing cortical granules whose enzymes modify the zona to prevent polyspermy (zona reaction). The oocyte completes meiosis II, extruding the second polar body. Male and female pronuclei form, migrate together, and fuse, creating the diploid zygote.
Panel A: Sperm transport through the female reproductive tract, showing cross-section from vagina through cervical canal with receptive mucus channels, uterine cavity, and fallopian tube, with decreasing sperm numbers at each level. Panel B: Capacitation changes comparing before (compact membrane, regular motility) and after (fluid membrane with cholesterol efflux, hyperactivated whip-like motility). Panel C: Oocyte structure with labeled layers including corona radiata, zona pellucida with ZP1/ZP2/ZP3 proteins, perivitelline space, and oocyte membrane with metaphase II spindle. Panel D: Sequential fertilization steps from corona penetration with hyaluronidase, acrosome reaction at zona, zona penetration by acrosin, membrane fusion, cortical granule release, second polar body extrusion, to pronuclear formation and zygote creation.
---
## Section 2: Early Embryonic Development - From Zygote to Blastocyst
Following fertilization, the zygote undergoes a series of mitotic divisions called cleavage while traversing the fallopian tube toward the uterus. These early cell divisions are unique in that the overall embryo size remains unchanged; cells (blastomeres) become progressively smaller with each division rather than the embryo enlarging.
The timeline of early development follows a precise schedule. The first cleavage division occurs approximately 30 hours post-fertilization, producing two cells. By 40 hours, four cells are present. At around three days post-fertilization, the embryo reaches the 8-cell stage, at which point compaction begins—cells maximize their contact with each other, establishing inside versus outside positions that will determine cell fate. The tight junctions and gap junctions forming between outer cells create the first epithelial barrier. By days 3-4, the embryo has become a morula (from Latin "mulberry"), a solid ball of 16 or more cells.
Blastocyst formation represents the first differentiation event. Between days 5-6, fluid accumulates within the morula, creating an expanding cavity called the blastocoel. The cells segregate into two distinct populations. The inner cell mass (embryoblast), a cluster of cells at one pole, will give rise to the embryo proper and certain extraembryonic structures. The outer cell layer (trophoblast) will form the placenta and chorion. This allocation depends on cell position—outside cells become trophoblast while inside cells become inner cell mass—as well as differential gene expression, particularly transcription factors such as Oct4 (pluripotency, inner cell mass) and Cdx2 (trophoblast).
Zona hatching must occur before implantation can proceed. The blastocyst secretes proteases that, combined with mechanical expansion, rupture the zona pellucida around days 5-6. The hatched blastocyst is now capable of direct contact with the endometrium.
Throughout this period, the embryo travels through the tube and enters the uterus around day 4, remaining free-floating in the uterine cavity for 2-3 days before implantation. During this time, the embryo is nourished by secretions from tubal and uterine glands. Importantly, maternal recognition of pregnancy has not yet occurred, and no hormonal changes are detectable.
Panel A: Horizontal developmental timeline with embryo illustrations at each stage from fertilization (day 0, zygote with two pronuclei) through 2-cell, 4-cell, 8-cell with compaction, morula, early blastocyst, expanded blastocyst, to hatching blastocyst emerging from zona on day 6. Panel B: Relative size scale demonstrating cells becoming smaller with each division while embryo size remains constant until blastocyst expansion. Panel C: Anatomical context showing fallopian tube cross-sections with embryo location at each stage and entry into the uterine cavity around day 4. Panel D: Blastocyst detail with inner cell mass labeled as future embryo (Oct4 marker) and trophoblast labeled as future placenta (Cdx2 marker).
---
## Section 3: Implantation and Decidualization
Implantation, the process by which the blastocyst establishes contact with and invades the endometrium, occurs during a limited window of receptivity between days 20-24 of the menstrual cycle (days 6-10 post-ovulation). This window requires precise synchronization between embryonic development and endometrial preparation.
The endometrium must be in the secretory phase, primed by progesterone from the corpus luteum following estrogen exposure during the proliferative phase. Progesterone induces structural and molecular changes that create receptivity. Pinopodes, mushroom-shaped protrusions from the apical surface of endometrial epithelial cells, appear transiently during the window of implantation and are thought to facilitate blastocyst attachment. The endometrium expresses adhesion molecules including integrins, selectins, and mucins that mediate embryo-endometrial interaction.
Implantation proceeds through three stages. During apposition, the blastocyst loosely associates with the endometrial surface, the inner cell mass oriented toward the endometrium (embryonic pole implantation). Adhesion follows, involving molecular interactions between trophoblast and endometrial receptors, including integrin-mediated binding. Invasion is the final stage, during which the trophoblast actively penetrates the endometrial epithelium and invades the stroma.
Trophoblast differentiation is essential for successful implantation. The outer trophoblast cells fuse to form the syncytiotrophoblast, a multinucleated invasive layer that produces human chorionic gonadotropin and other hormones. The inner cytotrophoblast cells remain as a single-celled layer that continually fuses into the overlying syncytium, maintaining it throughout pregnancy. Extravillous trophoblast cells invade the decidua and myometrium, critically including the spiral arteries, which they remodel into dilated, low-resistance vessels.
The decidual reaction describes the transformation of endometrial stroma into decidua under the influence of progesterone and embryonic signals. Decidual cells accumulate glycogen and lipid, becoming large and polygonal. They secrete prolactin, IGFBP-1, and other factors that support early pregnancy and regulate trophoblast invasion. Three regions of decidua are distinguished by their relationship to the implanted embryo: decidua basalis underlies the embryo and becomes the maternal component of the placenta, decidua capsularis covers the embryo as it grows into the uterine cavity, and decidua parietalis (or vera) lines the remainder of the uterine cavity.
Panel A: Endometrial surface during the implantation window showing cross-section with secretory-phase glands, pinopodes protruding from luminal epithelium, and adhesion molecule expression (integrins, selectins) at the surface. Panel B: Sequential implantation stages including apposition (blastocyst approaching epithelium), adhesion (molecular interactions highlighted), and invasion (trophoblast penetrating epithelium with syncytiotrophoblast formation at advancing edge). Panel C: Trophoblast differentiation with inner cytotrophoblast layer, outer multinucleated syncytiotrophoblast, and extravillous trophoblast cells invading stroma and remodeling spiral arteries (before and after comparison). Panel D: Sagittal uterine view showing decidual regions with implanted embryo: decidua basalis (under embryo), decidua capsularis (covering embryo), and decidua parietalis (rest of cavity).
---
## Section 4: Placental Development and Function
The placenta develops from the trophoblast and extraembryonic mesoderm to become the critical interface for maternal-fetal exchange. Its development proceeds through defined morphologic stages over the first trimester.
During the second week post-fertilization, the syncytiotrophoblast erodes into the endometrium, creating lacunae (spaces) that become filled with maternal blood as it breaches the spiral arteries and veins. This establishes the hemochorial circulation characteristic of human pregnancy, where maternal blood directly bathes fetal tissue.
Villous development progresses through three stages. Primary villi (week 3) consist of a cytotrophoblast core covered by syncytiotrophoblast. Secondary villi (week 4) acquire a core of extraembryonic mesoderm. Tertiary villi (week 5) contain fetal blood vessels connected to the embryonic circulation, establishing functional maternal-fetal exchange. As pregnancy advances, villi undergo extensive branching, increasing surface area for exchange.
The mature placenta at term weighs approximately 500 grams and measures 15-20 cm in diameter and 2-3 cm in thickness. The fetal surface (chorionic plate) is smooth and covered by amnion, with the umbilical cord inserting typically near the center. The maternal surface displays 15-20 cotyledons, which are villous tree units separated by decidual septa. The total villous surface area for exchange approximates 11 square meters.
Placental circulation comprises two separate but closely apposed systems. On the maternal side, spiral arteries (remodeled by extravillous trophoblast to become large, low-resistance conduits) deliver blood into the intervillous space at low pressure. Blood flows around and between villi, then drains through endometrial veins. On the fetal side, deoxygenated blood arrives via two umbilical arteries, flows through the villous capillary network where exchange occurs, and returns oxygenated via a single umbilical vein.
The placenta performs multiple essential functions. Gas exchange transfers oxygen from mother to fetus and carbon dioxide in the reverse direction, driven by concentration gradients and facilitated by fetal hemoglobin's higher oxygen affinity. Nutrient transfer includes facilitated diffusion for glucose, active transport for amino acids, and receptor-mediated endocytosis for immunoglobulin G. Waste products including urea, uric acid, and bilirubin cross from fetus to mother for maternal excretion. The placenta also provides immune barrier function, though IgG transfer confers passive immunity to the neonate.
Panel A: Villous evolution timeline showing primary villi (cytotrophoblast and syncytiotrophoblast only), secondary villi (with mesenchymal core added), and tertiary villi (with fetal blood vessels and capillaries containing fetal red blood cells). Panel B: Mature placental anatomy in cross-section showing fetal surface with smooth amnion and umbilical cord insertion, chorionic plate, villous trees in intervillous space, maternal blood flow from spiral arteries and drainage to veins, and maternal surface with cotyledons separated by septa. Panel C: Magnified terminal villus cross-section showing layers (syncytiotrophoblast, cytotrophoblast, basement membrane, fetal capillary endothelium) with transport mechanisms for O2/CO2 diffusion, glucose via GLUT transporters, amino acids via active transport, and IgG via receptor-mediated transcytosis. Panel D: Placental circulation diagram with dual systems showing remodeled spiral arteries delivering maternal blood at low pressure and fetal circulation via two umbilical arteries and one umbilical vein through the villous capillary network.
---
## Section 5: Placental Hormones
The placenta functions as a major endocrine organ, producing hormones essential for pregnancy maintenance, maternal metabolic adaptation, and preparation for lactation. Unlike typical endocrine organs, the placenta lacks autonomous synthetic capability for steroid hormones and relies on precursors from maternal and fetal compartments.
Human chorionic gonadotropin (hCG) is among the first hormones produced, detectable in maternal blood as early as 8-10 days post-ovulation. Synthesized by the syncytiotrophoblast, hCG is a glycoprotein composed of an alpha subunit shared with LH, FSH, and TSH, and a unique beta subunit that confers specificity and is the basis for pregnancy testing. The primary function of hCG is rescue of the corpus luteum from its programmed demise, ensuring continued progesterone production until the placenta assumes this role. HCG levels rise exponentially in early pregnancy, doubling approximately every 48 hours, peaking at 10-12 weeks, then declining and plateauing through the remainder of pregnancy. Extremely elevated hCG suggests multiple gestation or gestational trophoblastic disease, while abnormally low levels may indicate ectopic pregnancy or impending miscarriage.
Human placental lactogen (hPL), also called human chorionic somatomammotropin, is structurally similar to growth hormone and prolactin. Produced in increasing quantities proportional to placental mass, hPL reaches peak levels in late pregnancy. Its primary function is maternal metabolic adaptation: hPL promotes lipolysis, releasing free fatty acids for maternal fuel, and induces insulin resistance, ensuring glucose availability for the fetus. These actions contribute to the "diabetogenic" state of pregnancy.
Placental steroid hormone production relies on the fetoplacental unit—the interdependent metabolic cooperation between placenta and fetus. The placenta produces progesterone from maternal cholesterol but lacks 17-alpha hydroxylase and cannot convert progesterone to androgens. For estrogen synthesis, the placenta requires androgen precursors (DHEA-S) produced by the fetal adrenal gland. The placenta aromatizes these androgens to estrogens, primarily estriol (E3), which requires the 16-hydroxylation step performed by the fetal liver. Estriol levels therefore reflect fetal adrenal and hepatic function.
The luteal-placental shift describes the transition of progesterone production from corpus luteum to placenta. During the first 7-10 weeks, the corpus luteum is essential; luteectomy during this period causes pregnancy loss. By 10 weeks, placental progesterone production is sufficient, and the corpus luteum becomes dispensable.
Panel A: hCG production and function showing syncytiotrophoblast secreting hCG into maternal circulation, alpha-beta subunit molecular structure, corpus luteum rescue maintaining progesterone secretion, and plasma concentration curve peaking at 10-12 weeks then declining. Panel B: hPL with production proportional to placental mass, structural similarity to GH/prolactin, and metabolic effects including lipolysis releasing fatty acids from adipose and insulin resistance directing glucose to the fetus. Panel C: Fetoplacental unit for steroid synthesis showing maternal cholesterol to placental progesterone, fetal adrenal DHEA-S production, fetal liver 16-hydroxylation, and placental aromatization to estriol with precursor flow arrows between compartments. Panel D: Luteal-placental shift timeline showing corpus luteum progesterone production declining as placental production rises around weeks 8-10.
---
## Section 6: Maternal Cardiovascular Adaptations
Pregnancy induces profound cardiovascular changes to meet the metabolic demands of the growing fetus and prepare for blood loss at delivery. These adaptations begin in the first trimester, peak in the second trimester, and persist until the postpartum period.
Blood volume expansion is among the most dramatic changes. Plasma volume increases by 40-50% (approximately 1200-1500 mL above non-pregnant values) through sodium and water retention mediated by the renin-angiotensin-aldosterone system and estrogen. Red blood cell mass also increases, but to a lesser degree (20-30%), creating a relative hemodilution often termed physiologic anemia of pregnancy. Hemoglobin concentrations typically fall to 11-12 g/dL, and hematocrit to 33-36%. This hemodilution actually benefits uteroplacental perfusion by reducing blood viscosity.
Cardiac output increases by 30-50%, beginning in the first trimester and peaking around 25-30 weeks' gestation. This increase results from both elevated stroke volume (20-30% higher) and increased heart rate (10-20 beats per minute above baseline). Cardiac output remains elevated until delivery, with additional transient increases during labor due to uterine contractions returning blood to the central circulation.
Systemic vascular resistance decreases substantially due to the vasodilatory effects of progesterone, prostaglandins, nitric oxide, and relaxin. This vasodilation, despite the increased cardiac output, produces a net decrease in blood pressure during the first and second trimesters, reaching a nadir around 20-24 weeks (typically 5-10 mmHg below pre-pregnancy values). Blood pressure then gradually returns toward pre-pregnancy baseline in the third trimester.
The heart undergoes structural remodeling, with left ventricular mass increasing by approximately 50% (eccentric hypertrophy). Examination findings may include a third heart sound (S3), soft systolic flow murmurs, and jugular venous distension—all normal in pregnancy. The heart is displaced leftward and upward by the growing uterus, rotating the electrocardiographic axis.
Pregnancy creates a hypercoagulable state that provides protection against hemorrhage at delivery but increases thromboembolic risk. Clotting factors I (fibrinogen), VII, VIII, X, and von Willebrand factor are elevated. Protein S levels decrease. The net result is a 4-5 fold increased risk of venous thromboembolism, highest in the postpartum period.
Panel A: Central anatomical image of the pregnant heart displaced by gravid uterus with eccentric LV hypertrophy inset, and blood volume bar graph comparing plasma volume increase (50%) versus RBC mass increase (25%) demonstrating hemodilution. Panel B: Cardiac output curve across gestation showing rise through second trimester, plateau in third trimester, and abrupt changes during labor/delivery, with SVR curve inversely decreasing through mid-pregnancy. Panel C: Blood pressure curve showing decline to nadir at 20-24 weeks then gradual rise toward pre-pregnancy baseline in the third trimester. Panel D: Hemostasis diagram showing elevated procoagulant factors (fibrinogen, VII, VIII, X, vWF) and decreased protein S, with DVT risk illustration and summary table of key parameters (HR +10-20 bpm, SV +20-30%, CO +30-50%, SVR decreased).
---
## Section 7: Maternal Respiratory and Renal Adaptations
Pregnancy profoundly alters respiratory and renal physiology to accommodate increased metabolic demands and facilitate waste elimination for both mother and fetus.
Respiratory changes begin early and are driven primarily by progesterone, which stimulates the medullary respiratory center, increasing sensitivity to carbon dioxide. Tidal volume increases by approximately 40%, from around 500 mL to 700 mL, while respiratory rate remains essentially unchanged or increases slightly. The net effect is a 50% increase in minute ventilation (tidal volume × respiratory rate). This hyperventilation produces a chronic compensated respiratory alkalosis, with PaCO2 falling from the normal 40 mmHg to 28-32 mmHg. Serum bicarbonate decreases through renal compensation to approximately 18-21 mEq/L, maintaining pH at 7.40-7.45.
Anatomic changes also occur. The enlarging uterus elevates the diaphragm by approximately 4 cm, but diaphragmatic excursion actually increases due to relaxation of the costal attachments. Functional residual capacity decreases by 20% because of the reduced resting diaphragm position, making pregnant women more susceptible to hypoxemia during apneic episodes such as intubation. Despite these changes, vital capacity remains unchanged. Many pregnant women experience dyspnea, likely due to increased ventilatory drive and awareness of the deeper breathing pattern rather than true respiratory compromise.
Renal blood flow and glomerular filtration rate increase dramatically, beginning in the first trimester and reaching 50% above non-pregnant values by mid-pregnancy. This hyperfiltration results from increased cardiac output and renal vasodilation. The increased GFR has important clinical implications: serum creatinine falls to 0.5-0.8 mg/dL (a value of 0.9-1.0 may indicate renal impairment in pregnancy), and BUN decreases proportionally. The renal threshold for glucose reabsorption may be exceeded, producing glycosuria that does not necessarily indicate diabetes.
Anatomic changes include dilation of the renal collecting system (physiologic hydronephrosis), more pronounced on the right due to dextrorotation of the uterus and compression of the right ureter where it crosses the pelvic brim. The ureters also dilate. These changes predispose to urinary stasis and increased urinary tract infection risk.
Pregnancy affects interpretation of laboratory values: normal creatinine is lower, normal bicarbonate is lower, and normal PaCO2 is lower than in the non-pregnant state.
Panel A: Spirometry tracing comparing pregnant versus non-pregnant lung volumes, highlighting increased tidal volume, unchanged vital capacity, and decreased functional residual capacity, with anatomical view of elevated diaphragm and expanded rib cage. Panel B: Blood gas values in pregnancy (pH 7.40-7.45, PaCO2 28-32 mmHg, HCO3 18-21 mEq/L) indicating chronic compensated respiratory alkalosis, with progesterone acting on the medullary respiratory center. Panel C: Renal anatomical diagram showing dilated collecting systems (right greater than left), dilated ureters, gravid uterus causing right ureteral compression, and GFR graph showing 50% increase from the first trimester. Panel D: Pregnancy laboratory values table with creatinine 0.5-0.8 mg/dL and decreased BUN, warning that creatinine greater than 0.8-0.9 may indicate impairment, and inset showing glycosuria from exceeded tubular reabsorption threshold despite normal blood glucose.
---
## Section 8: Maternal Metabolic Adaptations
Pregnancy creates a unique metabolic environment designed to ensure adequate nutrient supply to the developing fetus while meeting the increased energy demands of the mother. These adaptations evolve across pregnancy, shifting from anabolic to catabolic patterns.
During the first half of pregnancy, maternal metabolism is predominantly anabolic. Insulin sensitivity is enhanced, promoting glucose uptake and storage as glycogen and fat in maternal tissues. Lipogenesis is increased. This period represents "maternal storage," building reserves that will support the more demanding second half of pregnancy. Weight gain during this period primarily reflects maternal tissue expansion (blood volume, breast tissue, fat stores).
The second half of pregnancy transitions to a relatively catabolic state characterized by progressive insulin resistance. This "diabetogenic" effect is mediated by placental hormones, particularly human placental lactogen, as well as cortisol, prolactin, and progesterone. These hormones counteract insulin action, reducing maternal glucose uptake and utilization. The result is elevated postprandial glucose levels that favor transplacental glucose transfer to the fetus via GLUT1 transporters (facilitated diffusion, concentration-gradient dependent).
In the fasting state, pregnancy is characterized as "accelerated starvation." After even brief fasting, pregnant women develop lower glucose levels, higher free fatty acid levels, and higher ketone levels compared to non-pregnant individuals. Lipolysis releases fatty acids that the mother uses for fuel, sparing glucose for fetal consumption. While ketones can cross the placenta, the fetus primarily depends on glucose.
Lipid metabolism changes substantially. Total cholesterol increases by approximately 50%, and triglycerides increase by 200-300%. These changes support placental steroid hormone synthesis and provide energy substrate for the mother.
Protein metabolism shifts to a positive nitrogen balance, an anabolic state that supports the synthesis of new maternal and fetal tissues. Serum albumin concentration decreases due to hemodilution, which affects interpretation of total calcium levels and drug binding.
Calcium metabolism adapts to meet fetal skeletal requirements (approximately 30 g of calcium by term). Intestinal calcium absorption doubles, mediated by increased 1,25-dihydroxyvitamin D. Despite this increased absorption, total serum calcium falls due to decreased albumin, but ionized (physiologically active) calcium remains normal. Parathyroid hormone levels are normal to slightly elevated.
Panel A: Timeline dividing pregnancy into first half (anabolic phase with increased insulin sensitivity, glycogen and fat storage) and second half (catabolic/diabetogenic phase with insulin resistance providing nutrients to fetus). Panel B: Insulin resistance mechanism showing hPL, cortisol, and progesterone blocking insulin receptor signaling on maternal muscle and fat cells, with glucose redirected across the placenta to the fetus. Panel C: Fasting state comparison with bar graphs showing lower glucose, higher free fatty acids, and higher ketones in pregnancy versus non-pregnant state (accelerated starvation), alongside lipid changes showing 50% cholesterol increase and 200-300% triglyceride increase. Panel D: Calcium metabolism with doubled intestinal absorption via active vitamin D, maternal-fetal calcium transfer to fetal skeleton, and ionized calcium remaining normal despite decreased total calcium from albumin hemodilution.
---
## Section 9: Fetal Development Overview
Fetal development proceeds through two major periods: the embryonic period (fertilization through week 8) characterized by organogenesis and maximal teratogenic vulnerability, and the fetal period (weeks 9-40) characterized by growth and functional maturation.
The embryonic period establishes all major organ systems. During week 1-2, the implanting blastocyst forms a bilaminar embryonic disc (epiblast and hypoblast). Week 3 brings gastrulation, the formation of the three primary germ layers (ectoderm, mesoderm, endoderm) through the primitive streak. The notochord induces neural plate formation. Week 4 marks neurulation (neural tube closure) and the beginning of cardiac contractions; failure of neural tube closure produces spina bifida or anencephaly. Weeks 5-8 see rapid organogenesis: limb buds appear and differentiate, facial structures form, and all major organ systems are established in rudimentary form. The embryonic period represents maximal vulnerability to teratogens, as disruption of organogenesis produces structural malformations.
The fetal period is characterized by growth and functional maturation. During the late first trimester (weeks 9-12), external genitalia become distinguishable, and the fetus begins to move though the mother cannot yet perceive this. The second trimester (weeks 13-26) brings rapid growth; quickening (maternal perception of fetal movement) occurs around 16-20 weeks. The eyes, which had fused shut, reopen. The auditory system matures. Surfactant production begins around 24 weeks, though insufficient for extrauterine survival. Viability, defined as the gestational age at which survival outside the uterus is possible, is approximately 22-24 weeks with intensive care. The third trimester (weeks 27-40) emphasizes weight gain (the fetus more than doubles its weight), fat deposition for temperature regulation, and final organ maturation, particularly of the lungs and brain.
Pulmonary maturation is essential for neonatal survival. Type II pneumocytes produce surfactant, a phospholipid-protein complex that reduces alveolar surface tension, preventing atelectasis. Surfactant production begins around 24 weeks but is insufficient until 34-36 weeks. The lecithin/sphingomyelin (L/S) ratio and presence of phosphatidylglycerol in amniotic fluid indicate lung maturity. Antenatal corticosteroids (betamethasone or dexamethasone) given to mothers at risk for preterm delivery accelerate surfactant production and reduce respiratory distress syndrome.
Panel A: Embryonic period (weeks 1-8) with stage illustrations including bilaminar disc (weeks 1-2), gastrulation with three germ layers through primitive streak (week 3), neural tube closure and cardiac tube beating (week 4), and progressive limb bud and facial feature development (weeks 5-8), with teratogen sensitivity banner. Panel B: Fetal period milestones at key stages: sex distinguishable (week 12, 9 cm), quickening (weeks 16-20, 20 cm), viability threshold with surfactant production beginning (week 24, 30 cm), lung maturity (weeks 34-36, 45 cm), and term (50 cm, 3.5 kg). Panel C: Lung maturity detail showing type II pneumocyte producing surfactant, L/S ratio graph increasing after 34 weeks, and antenatal corticosteroid injection accelerating maturation. Panel D: Growth curves showing fetal length and weight trajectories with third trimester acceleration and overall size progression from embryonic to fetal period.
---
## Section 10: Fetal Circulation
The fetal cardiovascular system is structurally and functionally distinct from the postnatal circulation, reflecting the different oxygen source (placenta rather than lungs) and the need to preferentially perfuse vital organs. Three shunts allow blood to bypass the non-functional lungs and liver.
Oxygenated blood returns from the placenta via a single umbilical vein, carrying the highest oxygen saturation in the fetal circulation (approximately 80%). This blood enters the fetal abdomen at the umbilicus and travels toward the liver. Approximately half the blood passes through the liver sinusoids, while the remainder bypasses the liver through the ductus venosus, a shunt connecting the umbilical vein to the inferior vena cava. This bypass preferentially delivers the most oxygenated blood toward the heart.
Blood entering the right atrium from the IVC is preferentially directed by the Eustachian valve toward the foramen ovale, an opening in the atrial septum covered by a flap valve. Blood flows from right to left atrium, then to the left ventricle and ascending aorta. This pathway ensures that the most oxygenated blood reaches the coronary arteries and brain first. The oxygen saturation in the ascending aorta is approximately 65%.
Deoxygenated blood returning from the upper body via the superior vena cava is directed preferentially into the right ventricle and pulmonary artery. However, because the fetal lungs are collapsed and fluid-filled with high vascular resistance, only approximately 10% of right ventricular output actually perfuses the lungs. The majority (approximately 90%) crosses from the pulmonary artery to the descending aorta via the ductus arteriosus, the third shunt. The descending aorta therefore carries mixed blood with lower oxygen saturation (approximately 60%), supplying the lower body and returning blood to the placenta via two umbilical arteries.
At birth, dramatic circulatory transition occurs. Cord clamping eliminates the low-resistance placental circulation, increasing systemic vascular resistance. The first breaths expand the lungs, decreasing pulmonary vascular resistance. Blood flow to the lungs increases dramatically, raising left atrial pressure. This increased left atrial pressure presses the foramen ovale valve closed. Rising oxygen tension and falling prostaglandin levels trigger functional closure of the ductus arteriosus (complete anatomic closure over weeks). The ductus venosus closes with cessation of umbilical venous flow. These shunts become the fossa ovalis, ligamentum arteriosum, and ligamentum venosum, respectively.
Panel A: Fetal heart and major vessels with color-coded oxygen saturations showing umbilical vein (80%), ductus venosus, IVC (70%), and preferential streaming through the foramen ovale to deliver oxygenated blood to the left heart and ascending aorta (65%) for coronary and cerebral perfusion. Panel B: Deoxygenated blood pathway from SVC through the right ventricle and pulmonary artery, with 90% shunting through the ductus arteriosus to the descending aorta (60%) and return to the placenta via umbilical arteries (60%). Panel C: Before and after birth comparison showing fetal circulation with three shunts converted to neonatal remnants (foramen ovale to fossa ovalis, ductus arteriosus to ligamentum arteriosum, ductus venosus to ligamentum venosum). Panel D: Transitional circulation triggers including first breath expanding lungs and decreasing pulmonary vascular resistance, cord clamping increasing systemic vascular resistance, increased PaO2, and decreased prostaglandins causing shunt closure.
---
## Summary
Fertilization occurs in the fallopian tube ampulla, requiring sperm capacitation and the acrosome reaction to penetrate the zona pellucida. The cortical reaction prevents polyspermy.
Early embryonic development proceeds from zygote through cleavage divisions to morula to blastocyst, with the inner cell mass forming the embryo and the trophoblast forming the placenta.
Implantation occurs during a limited endometrial window (days 20-24 of the cycle), involving apposition, adhesion, and trophoblast invasion with decidualization of the endometrium.
The placenta develops through primary, secondary, and tertiary villous stages, ultimately providing a large surface area for gas, nutrient, and waste exchange between hemochorial maternal-fetal circulations.
Placental hormones include hCG (maintains corpus luteum), hPL (maternal metabolic adaptation), and steroid hormones (progesterone and estrogens) produced through fetoplacental cooperation.
Maternal cardiovascular adaptations include 40-50% blood volume expansion, 30-50% increased cardiac output, decreased SVR, and hypercoagulability.
Maternal respiratory adaptations include 50% increased minute ventilation producing chronic compensated respiratory alkalosis.
Maternal renal adaptations include 50% increased GFR with lower normal creatinine values.
Maternal metabolic adaptations transition from early anabolic storage to late insulin resistance ("diabetogenic state") ensuring fetal glucose supply.
Fetal development comprises the embryonic period (weeks 1-8, organogenesis, teratogen-sensitive) and fetal period (weeks 9-40, growth and maturation, with viability around 24 weeks and lung maturity by 34-36 weeks).
Fetal circulation features three shunts (ductus venosus, foramen ovale, ductus arteriosus) that bypass the non-functional liver and lungs, closing at birth in response to cord clamping, first breath, and rising oxygen tension.
---
## Key Terms
| Term | Definition |
|------|------------|
| Capacitation | Final functional maturation of sperm occurring in the female reproductive tract |
| Blastocyst | Pre-implantation embryo with inner cell mass, trophoblast, and blastocoel cavity |
| Syncytiotrophoblast | Outer multinucleated invasive trophoblast layer producing placental hormones |
| Decidua | Transformed endometrium of pregnancy providing the maternal-placental interface |
| hCG | Human chorionic gonadotropin; glycoprotein hormone maintaining the corpus luteum |
| Luteal-placental shift | Transition of progesterone production from corpus luteum to placenta at 8-10 weeks |
| Ductus arteriosus | Fetal vascular shunt connecting pulmonary artery to descending aorta |
| Foramen ovale | Fetal interatrial opening allowing right-to-left blood flow |
---
*This content is subject to the [MIT License](https://opensource.org/licenses/MIT). © 2024–2026 Hibbert School of Medicine.*